NCT06275386View on ClinicalTrials.gov

Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 24, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

October 1, 2025

Conditions
Coronary Artery DiseaseTotal Occlusion of Coronary Artery
Interventions
DEVICE

Paclitaxel Drug-coated balloon

Percutaneous coronary intervention of the actual CTO body with a paclitaxel drug-coated balloon.

Trial Locations (1)

04-628

RECRUITING

National Institute of Cardiology, Warsaw

All Listed Sponsors
lead

National Institute of Cardiology, Warsaw, Poland

OTHER